AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 11375295 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium plus low doses of calcitriol
Number of subjects: 0
Study 11375295 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium plus conventional doses of calcitriol
Number of subjects: 0
Study 11375295 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study 10085993 — intervention group
Group type: EXPERIMENTAL
Intervention: COPE program
Number of subjects: 0
Study 9366972 — intervention group
Group type: EXPERIMENTAL
Intervention: Peptide T high dose (15 mg daily for four weeks)
Number of subjects: 9
Study 9366972 — intervention group
Group type: COMPARATOR
Intervention: Peptide T low dose (1.5 mg daily for four weeks)
Number of subjects: 9
Study 9366972 — intervention group
Group type: EXPERIMENTAL
Intervention: Comparison of high dose versus low dose Peptide T
Number of subjects: 9
Study 1760535 — intervention group
Group type: EXPERIMENTAL
Intervention: Felodipine 1.25 mg
Number of subjects: 10
Study 1760535 — intervention group
Group type: EXPERIMENTAL
Intervention: Felodipine 10 mg
Number of subjects: 10
Study 1760535 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 7046411 — intervention group
Group type: EXPERIMENTAL
Intervention: Brown rice
Number of subjects: 12
Study 7046411 — intervention group
Group type: COMPARATOR
Intervention: Ground brown rice
Number of subjects: 12
Study 7046411 — intervention group
Group type: COMPARATOR
Intervention: Glucose
Number of subjects: 12
Study 30716404 — intervention group
Group type: EXPERIMENTAL
Intervention: 300 mg secukinumab
Number of subjects: 237
Study 30716404 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 237
Study 28450529 — intervention group
Group type: EXPERIMENTAL
Intervention: Reactive phenotype
Number of subjects: 454
Study 28450529 — intervention group
Group type: EXPERIMENTAL
Intervention: Uninflamed phenotype
Number of subjects: 454
Study 27807110 — intervention group
Group type: EXPERIMENTAL
Intervention: 36-mm metal-on-XLPE articulation
Number of subjects: 56
Study 27807110 — intervention group
Group type: COMPARATOR
Intervention: 28-mm metal-on-XLPE articulation
Number of subjects: 56
Study 23425517 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined intervention of stress management techniques and dietary education (Mediterranean diet principle)
Number of subjects: 36
Study 23425517 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention specified)
Number of subjects: 36
Study 22310190 — intervention group
Group type: EXPERIMENTAL
Intervention: Virtual Fiberoptic Intubation (VFI) software
Number of subjects: 23
Study 22310190 — intervention group
Group type: COMPARATOR
Intervention: Control group (usual didactic method only)
Number of subjects: 23
Study 20615108 — intervention group
Group type: EXPERIMENTAL
Intervention: SMS-based insulin dose titration system
Number of subjects: 100
Study 20615108 — intervention group
Group type: COMPARATOR
Intervention: Conventional titration scheme
Number of subjects: 100
Study 18261788 — intervention group
Group type: EXPERIMENTAL
Intervention: Interventions to improve asthma control; specific interventions not detailed in the abstract.
Number of subjects: 0
Study 18261788 — intervention group
Group type: COMPARATOR
Intervention: Not applicable; control group not specified.
Number of subjects: 0
Study 15632102 — intervention group
Group type: EXPERIMENTAL
Intervention: Pioglitazone 45 mg/day
Number of subjects: 23
Study 15632102 — intervention group
Group type: COMPARATOR
Intervention: Metformin 2,000 mg/day
Number of subjects: 23
Study 12787301 — intervention group
Group type: EXPERIMENTAL
Intervention: Montelukast 5 mg
Number of subjects: 30
Study 12787301 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study 10573242 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination therapy with salmeterol (50 microg b.i.d.) and beclomethasone (400 microg b.i.d.)
Number of subjects: 40
Study 10573242 — intervention group
Group type: EXPERIMENTAL
Intervention: Monotherapy with beclomethasone (400 microg b.i.d.)
Number of subjects: 40
Study 10573242 — intervention group
Group type: EXPERIMENTAL
Intervention: Monotherapy with salmeterol (50 microg b.i.d.)
Number of subjects: 40
Study 9127726 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxcarbazepine (OXC)
Number of subjects: 249
Study 9127726 — intervention group
Group type: COMPARATOR
Intervention: Sodium Valproate (VPA)
Number of subjects: 249
Study 1540456 — intervention group
Group type: EXPERIMENTAL
Intervention: Uncontrolled IUP during surgery (first part of the study)
Number of subjects: 26
Study 1540456 — intervention group
Group type: EXPERIMENTAL
Intervention: Uncontrolled IUP during surgery (second part of the study)
Number of subjects: 26
Study 1540456 — intervention group
Group type: COMPARATOR
Intervention: Controlled IUP during surgery
Number of subjects: 26
Study 3987929 — intervention group
Group type: EXPERIMENTAL
Intervention: Pergolide
Number of subjects: 0
Study 3987929 — intervention group
Group type: COMPARATOR
Intervention: Placebo/Control
Number of subjects: 0
Study 31221292 — intervention group
Group type: EXPERIMENTAL
Intervention: Ad libitum Mediterranean diet (MedDiet)
Number of subjects: 65
Study 31221292 — intervention group
Group type: COMPARATOR
Intervention: Low-fat diet
Number of subjects: 65
Study 27633943 — intervention group
Group type: EXPERIMENTAL
Intervention: Relax to Sleep (RTS) intervention
Number of subjects: 48
Study 27633943 — intervention group
Group type: COMPARATOR
Intervention: Usual Care (UC)
Number of subjects: 48
Study 27050252 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D-K-Calcium co-supplementation (200 IU vitamin D, 90 μg vitamin K, 500 mg calcium)
Number of subjects: 60
Study 27050252 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study 24689093 — intervention group
Group type: EXPERIMENTAL
Intervention: Unsedated transnasal endoscopy (TNE)
Number of subjects: 100
Study 24689093 — intervention group
Group type: COMPARATOR
Intervention: Unsedated transoral endoscopy (TOE)
Number of subjects: 100
Study 23089445 — intervention group
Group type: EXPERIMENTAL
Intervention: Bioabsorbable staple-line reinforcement (Seamguard) during stapled hemorrhoidopexy (Group A)
Number of subjects: 100
Study 23089445 — intervention group
Group type: COMPARATOR
Intervention: Standard stapled hemorrhoidopexy without reinforcement (Group B)
Number of subjects: 100
Study 19603621 — intervention group
Group type: EXPERIMENTAL
Intervention: TMS‐2 Topography System
Number of subjects: 71
Study 19603621 — intervention group
Group type: EXPERIMENTAL
Intervention: Keratron Scout
Number of subjects: 71
Study 19603621 — intervention group
Group type: EXPERIMENTAL
Intervention: Pentacam
Number of subjects: 71
Study 17877601 — intervention group
Group type: EXPERIMENTAL
Intervention: Misoprostol 200 microg rectally (Group A)
Number of subjects: 80
Study 17877601 — intervention group
Group type: EXPERIMENTAL
Intervention: Misoprostol 400 microg rectally (Group B)
Number of subjects: 80
Study 17877601 — intervention group
Group type: COMPARATOR
Intervention: No drugs (Group C)
Number of subjects: 80
Study 15085026 — intervention group
Group type: EXPERIMENTAL
Intervention: Nizatidine (2 or 4 mg/kg i.v. for infants; 2.5 or 5 mg/kg oral for children; 150 mg capsule for adolescents and adults)
Number of subjects: 129
Study 15085026 — intervention group
Group type: COMPARATOR
Intervention: Nizatidine administration
Number of subjects: 129
Study 11673341 — intervention group
Group type: EXPERIMENTAL
Intervention: Stent implantation
Number of subjects: 351
Study 11673341 — intervention group
Group type: COMPARATOR
Intervention: Angioplasty alone
Number of subjects: 351
Study 8501628 — intervention group
Group type: EXPERIMENTAL
Intervention: Heparin-surface-modified (HSM) intraocular lenses (IOLs)
Number of subjects: 40
Study 8501628 — intervention group
Group type: COMPARATOR
Intervention: Conventional poly(methyl methacrylate) (PMMA) intraocular lenses (IOLs)
Number of subjects: 40
Study 3329126 — intervention group
Group type: EXPERIMENTAL
Intervention: Sucrose-enriched diet (about 20 g sucrose per day)
Number of subjects: 10
Study 3329126 — intervention group
Group type: COMPARATOR
Intervention: Conventional diet
Number of subjects: 10
Study 3329126 — intervention group
Group type: EXPERIMENTAL
Intervention: Sucrose-enriched diet
Number of subjects: 10
Study 31912903 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral hygiene regimen (OHR) for 2 weeks
Number of subjects: 30
Study 31912903 — intervention group
Group type: COMPARATOR
Intervention: PBS(−/−) control
Number of subjects: 30
Study 29214461 — intervention group
Group type: EXPERIMENTAL
Intervention: CHO‐C (Carbohydrate + Sodium Caseinate Protein)
Number of subjects: 11
Study 29214461 — intervention group
Group type: EXPERIMENTAL
Intervention: CHO‐H (Carbohydrate + Sodium Caseinate Protein Hydrolysate)
Number of subjects: 11
Study 29214461 — intervention group
Group type: COMPARATOR
Intervention: CHO (Carbohydrate)
Number of subjects: 11
Study 28787506 — intervention group
Group type: EXPERIMENTAL
Intervention: Azithromycin (250 mg, 3 times a week for 2 years)
Number of subjects: 480
Study 28787506 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 480
Study 28787506 — intervention group
Group type: EXPERIMENTAL
Intervention: Azithromycin
Number of subjects: 480
Study 26245599 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiforce® (MF) Alkaline Powder, 7.5 g twice daily
Number of subjects: 100
Study 26245599 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study 23117443 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard aftercare plus biweekly telephone monitoring and support for three months after discharge
Number of subjects: 837
Study 23117443 — intervention group
Group type: COMPARATOR
Intervention: Standard outpatient aftercare
Number of subjects: 837
Study 23117443 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (telephone monitoring and treatment as usual)
Number of subjects: 837
Study 23117443 — intervention group
Group type: EXPERIMENTAL
Intervention: Telephone care management
Number of subjects: 837
Study 20602331 — intervention group
Group type: EXPERIMENTAL
Intervention: Online hemodiafiltration (OL-HDF)
Number of subjects: 906
Study 20602331 — intervention group
Group type: COMPARATOR
Intervention: Standard hemodialysis (HD)
Number of subjects: 906
Study 18428211 — intervention group
Group type: EXPERIMENTAL
Intervention: Lamotrigine (target dose of 300 mg/day)
Number of subjects: 131
Study 18428211 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 131
Study 16597731 — intervention group
Group type: EXPERIMENTAL
Intervention: Hand-object illusion (vibrated tendon of the wrist extensor muscle while touching an object)
Number of subjects: 12
Study 16597731 — intervention group
Group type: COMPARATOR
Intervention: Control 1 (vibrated skin surface over nearby bone)
Number of subjects: 12
Study 16597731 — intervention group
Group type: COMPARATOR
Intervention: Control 2 (vibrated tendon when hand did not touch the object)
Number of subjects: 12
Study 12588325 — intervention group
Group type: EXPERIMENTAL
Intervention: ATG
Number of subjects: 55
Study 12588325 — intervention group
Group type: EXPERIMENTAL
Intervention: OKT3
Number of subjects: 55
Study 10638899 — intervention group
Group type: EXPERIMENTAL
Intervention: Sevoflurane at concentrations ranging from 0.45% to 0.85%
Number of subjects: 96
Study 9338951 — intervention group
Group type: EXPERIMENTAL
Intervention: Diet
Number of subjects: 208
Study 9338951 — intervention group
Group type: EXPERIMENTAL
Intervention: Diet and exercise
Number of subjects: 208
Study 9338951 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise
Number of subjects: 208
Study 9338951 — intervention group
Group type: COMPARATOR
Intervention: No active intervention
Number of subjects: 208
Study 8247917 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination therapy with DTZ SR-HCTZ 120 mg-12.5 mg
Number of subjects: 298
Study 8247917 — intervention group
Group type: EXPERIMENTAL
Intervention: Monotherapy with DTZ SR 120 mg
Number of subjects: 298
Study 8247917 — intervention group
Group type: EXPERIMENTAL
Intervention: Monotherapy with HCTZ 12.5 mg
Number of subjects: 298
Study 8247917 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 298
Study 3479525 — intervention group
Group type: EXPERIMENTAL
Intervention: Lecithin treatment
Number of subjects: 37
Study 3479525 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 37
Study 31299247 — intervention group
Group type: EXPERIMENTAL
Intervention: Oropharyngeal spray (10 actuations of 10% lignocaine, group B)
Number of subjects: 1050
Study 29120964 — intervention group
Group type: EXPERIMENTAL
Intervention: vemurafenib
Number of subjects: 1310
Study 29120964 — intervention group
Group type: EXPERIMENTAL
Intervention: ipilimumab
Number of subjects: 1310
Study 29120964 — intervention group
Group type: EXPERIMENTAL
Intervention: dabrafenib
Number of subjects: 1310
Study 28182565 — intervention group
Group type: EXPERIMENTAL
Intervention: Dyspnoea-12 (D-12)
Number of subjects: 84
Study 28182565 — intervention group
Group type: EXPERIMENTAL
Intervention: Multidimensional Dyspnoea Profile (MDP)
Number of subjects: 84
Study 28182565 — intervention group
Group type: COMPARATOR
Intervention: D-12 and MDP
Number of subjects: 84
Study 26224811 — intervention group
Group type: EXPERIMENTAL
Intervention: Extracranial systemic embolic events (SEEs)
Number of subjects: 37973
Study 26224811 — intervention group
Group type: COMPARATOR
Intervention: Stroke
Number of subjects: 37973
Study 26224811 — intervention group
Group type: EXPERIMENTAL
Intervention: SEEs involving lower extremity
Number of subjects: 37973
Study 26224811 — intervention group
Group type: EXPERIMENTAL
Intervention: SEEs involving visceral-mesenteric
Number of subjects: 37973
Study 26224811 — intervention group
Group type: EXPERIMENTAL
Intervention: SEEs involving upper extremity
Number of subjects: 37973
Study 26224811 — intervention group
Group type: EXPERIMENTAL
Intervention: SEE-related care
Number of subjects: 37973
Study 26224811 — intervention group
Group type: EXPERIMENTAL
Intervention: Recovery within 30 days after SEE
Number of subjects: 37973
Study 26224811 — intervention group
Group type: EXPERIMENTAL
Intervention: Thirty-day mortality after SEE
Number of subjects: 37973
Study 26224811 — intervention group
Group type: EXPERIMENTAL
Intervention: Relative risk of death after SEE
Number of subjects: 37973
Study 26224811 — intervention group
Group type: COMPARATOR
Intervention: Relative risk of death after stroke
Number of subjects: 37973
Study 22878377 — intervention group
Group type: EXPERIMENTAL
Intervention: Unilateral fixation
Number of subjects: 116
Study 22878377 — intervention group
Group type: COMPARATOR
Intervention: Bilateral fixation
Number of subjects: 116
Study 22040388 — intervention group
Group type: EXPERIMENTAL
Intervention: Computer-tailored intervention (CTI) based on the transtheoretical model (TTM)
Number of subjects: 350
Study 19639073 — intervention group
Group type: COMPARATOR
Intervention: Kukident Classic (control adhesive)
Number of subjects: 24
Study 19639073 — intervention group
Group type: EXPERIMENTAL
Intervention: Kukident Pro (experimental adhesive)
Number of subjects: 24
Study 19639073 — intervention group
Group type: COMPARATOR
Intervention: Nonadhesive group
Number of subjects: 24
Study 19639073 — intervention group
Group type: EXPERIMENTAL
Intervention: Maxillary and mandibular dentures (both adhesive groups)
Number of subjects: 24
Study 19639073 — intervention group
Group type: EXPERIMENTAL
Intervention: Subjective evaluation of both adhesives
Number of subjects: 24
Study 17468862 — intervention group
Group type: EXPERIMENTAL
Intervention: Curcumin (300 mg day(-1) for 6 days)
Number of subjects: 12
Study 17468862 — intervention group
Group type: COMPARATOR
Intervention: Talinolol (50 mg single oral dose)
Number of subjects: 12
Study 15041571 — intervention group
Group type: EXPERIMENTAL
Intervention: IV-ECG guidance (Group E)
Number of subjects: 60
Study 15041571 — intervention group
Group type: COMPARATOR
Intervention: Surface landmark technique (Group S)
Number of subjects: 60
Study 11783748 — intervention group
Group type: EXPERIMENTAL
Intervention: Motivational Interviewing techniques
Number of subjects: 60
Study 11783748 — intervention group
Group type: COMPARATOR
Intervention: Standard evaluation
Number of subjects: 60
Study 9000151 — intervention group
Group type: EXPERIMENTAL
Intervention: Nedocromil sodium
Number of subjects: 7
Study 9000151 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 7
Study 8489440 — intervention group
Group type: EXPERIMENTAL
Intervention: Prophylactic surfactant therapy
Number of subjects: 86
Study 8489440 — intervention group
Group type: COMPARATOR
Intervention: Control (no prophylactic surfactant)
Number of subjects: 86
Study 3829723 — intervention group
Group type: EXPERIMENTAL
Intervention: Aqueous anthralin cream (Drithocreme) applied overnight
Number of subjects: 20
Study 3829723 — intervention group
Group type: COMPARATOR
Intervention: Aqueous anthralin cream (Drithocreme) applied for thirty minutes
Number of subjects: 20
Study 29164444 — intervention group
Group type: EXPERIMENTAL
Intervention: START program (20-week multi-component socialization intervention)
Number of subjects: 40
Study 29164444 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control group
Number of subjects: 40
Study 27256720 — intervention group
Group type: EXPERIMENTAL
Intervention: SIIIN2
Number of subjects: 65
Study 27256720 — intervention group
Group type: EXPERIMENTAL
Intervention: SIIIDTG
Number of subjects: 65
Study 24447053 — intervention group
Group type: EXPERIMENTAL
Intervention: High-frequency repetitive transcranial magnetic stimulation (HF-rTMS)
Number of subjects: 20
Study 24447053 — intervention group
Group type: COMPARATOR
Intervention: Sham control
Number of subjects: 20
Study 23526939 — intervention group
Group type: EXPERIMENTAL
Intervention: Newly developed eGFR formulas (eGFR7 and eGFR8) using serum CysC detection alone or in combination with serum Cr detection
Number of subjects: 788
Study 23526939 — intervention group
Group type: COMPARATOR
Intervention: eGFR1 (Cockcroft-Gault equation)
Number of subjects: 788
Study 23526939 — intervention group
Group type: COMPARATOR
Intervention: eGFR2 (MDRD formula)
Number of subjects: 788
Study 23526939 — intervention group
Group type: COMPARATOR
Intervention: eGFR3 (CKD-EPI formula)
Number of subjects: 788
Study 23526939 — intervention group
Group type: COMPARATOR
Intervention: eGFR4 (CKD-EPI formula)
Number of subjects: 788
Study 23526939 — intervention group
Group type: COMPARATOR
Intervention: eGFR5 (Chinese eGFR Investigation Collaboration formula)
Number of subjects: 788
Study 23526939 — intervention group
Group type: COMPARATOR
Intervention: eGFR6 (Chinese eGFR Investigation Collaboration formula)
Number of subjects: 788
Study 23526939 — intervention group
Group type: EXPERIMENTAL
Intervention: eGFR7 and eGFR8
Number of subjects: 788
Study 20543286 — intervention group
Group type: EXPERIMENTAL
Intervention: High extraversion
Number of subjects: 0
Study 20543286 — intervention group
Group type: COMPARATOR
Intervention: Social exclusion and existential anxiety
Number of subjects: 0
Study 17543392 — intervention group
Group type: EXPERIMENTAL
Intervention: Group treatment
Number of subjects: 130
Study 17543392 — intervention group
Group type: COMPARATOR
Intervention: Internet-based treatment
Number of subjects: 130
Study 15722381 — intervention group
Group type: EXPERIMENTAL
Intervention: Catheter over-needle technique (22G Spinocath, B. Braun, Germany)
Number of subjects: 18
Study 15722381 — intervention group
Group type: COMPARATOR
Intervention: Catheter through-needle technique (MicroCatheter, Portex, UK)
Number of subjects: 18
Study 12959681 — intervention group
Group type: EXPERIMENTAL
Intervention: Ticarcillin/clavulanic acid (T)
Number of subjects: 70
Study 12959681 — intervention group
Group type: COMPARATOR
Intervention: Ceftriaxone plus amikacin (C+A)
Number of subjects: 70
Study 10549683 — intervention group
Group type: EXPERIMENTAL
Intervention: Zolpidem, 10 mg nightly for 4 weeks
Number of subjects: 240
Study 10549683 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 240
Study 8895263 — intervention group
Group type: EXPERIMENTAL
Intervention: Desflurane (Group 4)
Number of subjects: 80
Study 8895263 — intervention group
Group type: COMPARATOR
Intervention: Sevoflurane (Group 1)
Number of subjects: 80
Study 8895263 — intervention group
Group type: COMPARATOR
Intervention: Halothane (Group 2)
Number of subjects: 80
Study 8895263 — intervention group
Group type: COMPARATOR
Intervention: Halothane (Group 3)
Number of subjects: 80
Study 8895263 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 80
Study 2050833 — intervention group
Group type: EXPERIMENTAL
Intervention: Moclobemide (100 mg TID)
Number of subjects: 12
Study 2050833 — intervention group
Group type: EXPERIMENTAL
Intervention: Phenelzine (15 mg TID)
Number of subjects: 12
Study 2050833 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 2050833 — intervention group
Group type: EXPERIMENTAL
Intervention: Norepinephrine
Number of subjects: 12
Study 6219902 — intervention group
Group type: EXPERIMENTAL
Intervention: Erythromycin stearate tablets (500 mg twice a day for 2 weeks)
Number of subjects: 20
Study 6219902 — intervention group
Group type: COMPARATOR
Intervention: Erythromycin enteric-coated base capsules (500 mg twice a day for 2 weeks)
Number of subjects: 20
Study 31308105 — intervention group
Group type: EXPERIMENTAL
Intervention: Addition of a non‐directional educational message on the risk of ionising radiation to all CT reports
Number of subjects: 0
Study 31308105 — intervention group
Group type: COMPARATOR
Intervention: Control hospital (no intervention)
Number of subjects: 0
Study 30119152 — intervention group
Group type: EXPERIMENTAL
Intervention: Volume-controlled equal ratio ventilation (VC-ERV)
Number of subjects: 111
Study 30119152 — intervention group
Group type: COMPARATOR
Intervention: Volume-controlled conventional ratio ventilation (VC-CRV)
Number of subjects: 111
Study 26778138 — intervention group
Group type: EXPERIMENTAL
Intervention: Compression garments (full‐length compression top and compression shorts) during exercise and overnight recovery
Number of subjects: 10
Study 26778138 — intervention group
Group type: COMPARATOR
Intervention: Normal work clothes (control condition)
Number of subjects: 10
Study 24578164 — intervention group
Group type: EXPERIMENTAL
Intervention: Resynchronization therapy (CRT-D)
Number of subjects: 191
Study 24578164 — intervention group
Group type: COMPARATOR
Intervention: Control group (standard care)
Number of subjects: 191
Study 22128223 — intervention group
Group type: EXPERIMENTAL
Intervention: Eplerenone
Number of subjects: 5792
Study 22128223 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 5792
Study 19053987 — intervention group
Group type: EXPERIMENTAL
Intervention: pantoprazole 80 mg + 8 mg/h for 72 h
Number of subjects: 1256
Study 19053987 — intervention group
Group type: COMPARATOR
Intervention: ranitidine 50 mg + 13 mg/h for 72 h
Number of subjects: 1256
Study 16891136 — intervention group
Group type: EXPERIMENTAL
Intervention: levalbuterol 0.31 mg via nebulizer
Number of subjects: 262